Telesis Bio Inc reports results for the quarter ended in June - Earnings Summary

Telesis Bio

08/08/2024 22:01

* Telesis Bio Inc  TBIO.OQ  reported a quarterly adjusted
loss of
$7.62​​ per share for the quarter ended in June, lower than the
same quarter last year, when the company reported EPS of
$-5.04.  The lone analyst forecast for the quarter was for a
loss of $4.03 per share. 
    * Revenue fell 82.1% to $1.55 million from a year ago;
analysts
expected $6.50 million. 
    * Telesis Bio Inc shares had risen by 16.4% this quarter and
lost 40.8% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the advanced
medical
equipment & technology peer group is also "buy"

This summary was machine generated from LSEG data August 8 at
09:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2024      -4.03          -7.62          Missed
 Mar. 31 2024      -4.14          -5.52          Missed
 Dec. 31 2023      -3.96          -4.14          Missed
 Sep. 30 2023      -5.34          -6.66          Missed